Skip Navigation


Briefings in Functional Genomics and Proteomics Advance Access originally published online on May 27, 2009
Briefings in Functional Genomics and Proteomics 2009 8(3):170-173; doi:10.1093/bfgp/elp012
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
8/3/170    most recent
elp012v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hey, Y.
Right arrow Articles by Pepper, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hey, Y.
Right arrow Articles by Pepper, S. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. For permissions, please email: journals.permissions@oxfordjournals.org

This article appears in the following Briefings in Functional Genomics and Proteomics issue: Special Issue: The Future of Microarrays in an age of high throughput sequencing [View the issue table of contents]

Special Issue Papers

Interesting times for microarray expression profiling

Yvonne Hey and Stuart D. Pepper

Corresponding author. Stuart Pepper, Cancer Research UK Molecular Biology Core Facility, Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Withington, Manchester M20 4BX, UK. Tel: +44-161-446-3184; Fax: +44-161-446-3109; E-mail: spepper{at}picr.man.ac.uk

The last 10 years have seen microarrays go from being a nascent technology available only in a limited range of research facilities to becoming a ubiquitous approach to expression profiling. Developments in microarray technology have allowed the content of arrays to increase to the point that complete transcriptomes can be assayed on a single array, whilst developments in RNA labelling technology have reduced the amount of RNA needed down to the point where single cell profiling is technically possible. Recently it has also become possible to generate expression data from formalin-fixed paraffin-embedded archival samples. With the range of samples that can now be successfully profiled by microarray analysis this should be a good time to be running a microarray core facility. However, the arrival of Next Generation Sequencers means that for the first time there is an alternate platform that can potentially give a more complete picture of cellular expression than a microarray. Next Generation Sequencers are still in their infancy as a platform for expression profiling. Currently there are simply not enough Next Generation Sequencers in operation to meet the level of demand for expression profiling that microarray facilities service, but more systems are constantly becoming available. Looking ahead it seems certain that some proportion of expression profiling work will move from microarrays to Next Generation Sequencers, so now is a good time to consider some of the factors that might affect how significant that switch will be.

Keywords: microarray, clonal sequencer, next generation sequencer, expression profiling


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.